The Use of Molecular Subtypes for Precision Therapy of Recurrent and Metastatic Gastrointestinal Stromal Tumor

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumor in the digestive tract. Tyrosine kinase inhibitors (TKIs), represented by imatinib, sunitinib, and regorafenib, have become the main treatment for recurrent and metastatic GISTs. With the wide application of mutation analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Peng, Tan, Fengbo, Liu, Heli, Li, Bin, Lei, Tianxiang, Zhao, Xianhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102917/
https://www.ncbi.nlm.nih.gov/pubmed/32273716
http://dx.doi.org/10.2147/OTT.S241331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102917/
https://www.ncbi.nlm.nih.gov/pubmed/32273716
http://dx.doi.org/10.2147/OTT.S241331

Ejemplares similares